Insider trade

Bioaffinity Technologies (BIAF): 10% owner bought ~$231K

HRT FINANCIAL LP, 10% owner at Bioaffinity Technologies, bought ~$231K of Bioaffinity Technologies shares.

~$231K
Approx. value · 30K sh @ $7.67
131K
Holds after · shares reported
Traded
Sep 24, 2026
Filed
Nov 19, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 30, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On July 30, 2026, bioAffinity Technologies, Inc., a Delaware corporation (the “Company”) received written notice (the “Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined that the bid price of the Company’s listed securities has closed at less than $1.00 per share over the previous thirty consecutive business…”
  2. Aug 7, 2026Company filing · Form 8-K · ResultsReported its results
  3. Aug 12, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
  4. Aug 20, 2026Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year (and 1 more item)
  5. Sep 22, 2026Insider · 1 personInsiders: 1 purchase (~$163K), 1 sale (~$61K)
  6. Sep 23, 2026Insider · 1 personInsiders: 2 purchases (~$149K), 3 sales (~$176K)
  7. Sep 24, 2026 · this disclosureInsider10% owner purchased ~$231K of BIAF shares in the open market

What came next

  1. Sep 24, 2026Insider · 1 personInsiders: 2 sales (~$211K)
  2. Sep 25, 2026Insider · 1 personInsiders: 1 purchase (~$57K), 2 sales (~$72K)
  3. Sep 28, 2026Insider · 1 personInsiders: 2 purchases (~$82K), 2 sales (~$106K)
  4. Sep 29, 2026Insider · 1 personInsiders: 2 purchases (~$160K), 2 sales (~$143K)
  5. Sep 30, 2026Insider · 1 personInsiders: 1 purchase (~$82K), 1 sale (~$138K)
  6. Oct 1, 2026Insider · 1 personInsiders: 1 purchase (~$117K), 1 sale (~$268K)
  7. Oct 8, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
  8. Nov 6, 2026Company filing · Form 8-K · ResultsReported its results
  9. Nov 19, 20265% stakeHRT FINANCIAL LP reported a passive stake (13G) of 10.9%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Bioaffinity Technologies

For Bioaffinity Technologies, OQRO holds 25 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BIAF page.

Other recent filings by HRT FINANCIAL LP, 10% owner

The full history of HRT FINANCIAL LP, 10% owner is on the profile page.

How this filing works

Explore the data

Common questions

Which Bioaffinity Technologies (BIAF) insider traded, and how much?

HRT FINANCIAL LP, 10% owner at Bioaffinity Technologies, bought ~$231K of Bioaffinity Technologies shares. 30K shares at $7.67, open market.

When did it happen, and when was it made public?

Traded: Sep 24, 2026. Filed: Nov 19, 2026. That is 56 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Bioaffinity Technologies recently?

For Bioaffinity Technologies, OQRO holds 25 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BIAF page.

Does this mean BIAF stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Bioaffinity Technologies

Everything OQRO holds on this company is on its BIAF page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data